Continuous and intermittent levamisole. A controlled trial.
A double-blind comparative trial showed that intermittent levamisole therapy (150 mg daily for 3 days of each week) was as effective as continuous therapy (150 mg daily) in rheumatoid arthritis and with slightly fewer side effects.
Bewaard in:
| Gepubliceerd in: | Ann Rheum Dis |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
1978
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1000218/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/356761/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.37.3.259 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|